{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:01:51Z","timestamp":1791615711010,"version":"4.3.4"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00210-025-04747-y","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:45:10Z","timestamp":1761115510000},"page":"4475-4493","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Ophthalmic-targeted brinzolamide-laden cubosomal solid lipid nano-vesicular system (Cube-SLNV): design, development, and in vitro and ex vivo characterization"],"prefix":"10.1007","volume":"399","author":[{"given":"Hardik","family":"Rana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ujash","family":"Bhalodia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayushi","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishali","family":"Thakkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansi","family":"Dholakia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetna","family":"Modi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejal","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"key":"4747_CR1","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1080\/10717544.2018.1477858","volume":"25","author":"HM Aboud","year":"2018","unstructured":"Aboud HM, Hassan AH, Ali AA, Abdel-Razik ARH (2018) Novel in situ gelling vaginal sponges of sildenafil citrate-based cubosomes for uterine targeting. Drug Deliv 25:1328\u20131339. https:\/\/doi.org\/10.1080\/10717544.2018.1477858","journal-title":"Drug Deliv"},{"key":"4747_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/978-3-030-27492-4_3","volume-title":"Extemporaneous Ophthalmic Preparations","author":"EAS Alghamdi","year":"2020","unstructured":"Alghamdi EAS, Al Qahtani AY, Sinjab MM, Alyahya KM (2020) Ideal characteristics of ophthalmic drug delivery system. Extemporaneous Ophthalmic Preparations. Springer, Cham, pp 9\u201310"},{"key":"4747_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.101710","volume":"57","author":"WS Alharbi","year":"2020","unstructured":"Alharbi WS, Hosny KM (2020) Development and optimization of ocular in situ gels loaded with ciprofloxacin cubic liquid crystalline nanoparticles. J Drug Deliv Sci Technol 57:101710. https:\/\/doi.org\/10.1016\/j.jddst.2020.101710","journal-title":"J Drug Deliv Sci Technol"},{"key":"4747_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s43094-024-00607-3","author":"P Badiger","year":"2024","unstructured":"Badiger P, Mannur VS, Koli R (2024) Dual drug-loaded cubosome nanoparticles for hepatocellular carcinoma: a design of experiment approach for optimization and in vitro evaluation. Futur J Pharm Sci. https:\/\/doi.org\/10.1186\/s43094-024-00607-3","journal-title":"Futur J Pharm Sci"},{"key":"4747_CR5","doi-asserted-by":"crossref","unstructured":"Bhujbal S, Rupenthal ID, Agarwal P (2025) Evaluation of ocular tolerability and bioavailability of tonabersat transfersomes ex vivo","DOI":"10.1007\/s13346-025-01872-2"},{"key":"4747_CR6","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ejpb.2018.11.009","volume":"134","author":"L Boge","year":"2019","unstructured":"Boge L, Hallstensson K, Ringstad L et al (2019) Cubosomes for topical delivery of the antimicrobial peptide LL-37. Eur J Pharm Biopharm 134:60\u201367. https:\/\/doi.org\/10.1016\/j.ejpb.2018.11.009","journal-title":"Eur J Pharm Biopharm"},{"key":"4747_CR7","unstructured":"(2021) Brinzolamide: uses, interactions, mechanism of action | DrugBank Online"},{"key":"4747_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2021.105150","author":"P Budai","year":"2021","unstructured":"Budai P, Kormos \u00c9, Buda I et al (2021) Comparative evaluation of HET-CAM and ICE methods for objective assessment of ocular irritation caused by selected pesticide products. Toxicol In Vitro. https:\/\/doi.org\/10.1016\/j.tiv.2021.105150","journal-title":"Toxicol In Vitro"},{"key":"4747_CR9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ejpb.2022.09.008","volume":"180","author":"O Cegielska","year":"2022","unstructured":"Cegielska O, Sierakowski M, Sajkiewicz P et al (2022) Mucoadhesive brinzolamide-loaded nanofibers for alternative glaucoma treatment. Eur J Pharm Biopharm 180:48\u201362. https:\/\/doi.org\/10.1016\/j.ejpb.2022.09.008","journal-title":"Eur J Pharm Biopharm"},{"key":"4747_CR10","doi-asserted-by":"publisher","first-page":"s502","DOI":"10.5530\/ijper.58.2s.52","volume":"58","author":"SS Chakorkar","year":"2024","unstructured":"Chakorkar SS, Mulla JASG (2024) Cubosome-based corticosteroidal drug delivery system for sustained ocular delivery: a pharmacokinetic investigation. Indian J Pharm Educ Res 58:s502\u2013s514. https:\/\/doi.org\/10.5530\/ijper.58.2s.52","journal-title":"Indian J Pharm Educ Res"},{"key":"4747_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ma14123197","author":"H Cort\u00e9s","year":"2021","unstructured":"Cort\u00e9s H, Hern\u00e1ndez-Parra H, Bernal-Ch\u00e1vez SA (2021) Non-ionic surfactants for stabilization of polymeric nanoparticles for biomedical uses. Materials. https:\/\/doi.org\/10.3390\/ma14123197","journal-title":"Materials"},{"key":"4747_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nano10112272","volume":"10","author":"A Cytryniak","year":"2020","unstructured":"Cytryniak A, Nazaruk E, Bilewicz R et al (2020) Lipidic cubic-phase nanoparticles (Cubosomes) loaded with doxorubicin and labeled with177 lu as a potential tool for combined chemo and internal radiotherapy for cancers. Nanomaterials 10:1\u201314. https:\/\/doi.org\/10.3390\/nano10112272","journal-title":"Nanomaterials"},{"key":"4747_CR13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.22270\/jddt.v10i1.3814","volume":"10","author":"A Dhadwal","year":"2020","unstructured":"Dhadwal A, Sharma DR, Pandit V et al (2020) Cubosomes: a novel carrier for transdermal drug delivery. J Drug Deliv Ther 10:123\u2013130. https:\/\/doi.org\/10.22270\/jddt.v10i1.3814","journal-title":"J Drug Deliv Ther"},{"key":"4747_CR14","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.ijbiomac.2019.10.219","volume":"152","author":"V Dubey","year":"2020","unstructured":"Dubey V, Mohan P, Dangi JS, Kesavan K (2020) Brinzolamide loaded chitosan-pectin mucoadhesive nanocapsules for management of glaucoma: formulation, characterization and pharmacodynamic study. Int J Biol Macromol 152:1224\u20131232. https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.10.219","journal-title":"Int J Biol Macromol"},{"key":"4747_CR15","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jddst.2019.04.036","volume":"52","author":"AE Eldeeb","year":"2019","unstructured":"Eldeeb AE, Salah S, Ghorab M (2019) Formulation and evaluation of cubosomes drug delivery system for treatment of glaucoma: ex-vivo permeation and in-vivo pharmacodynamic study. J Drug Deliv Sci Technol 52:236\u2013247. https:\/\/doi.org\/10.1016\/j.jddst.2019.04.036","journal-title":"J Drug Deliv Sci Technol"},{"key":"4747_CR16","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.jsps.2018.04.004","volume":"26","author":"HA El-Enin","year":"2018","unstructured":"El-Enin HA, AL-Shanbari AH (2018) Nanostructured liquid crystalline formulation as a remarkable new drug delivery system of anti-epileptic drugs for treating children patients. Saudi Pharm J 26:790\u2013800. https:\/\/doi.org\/10.1016\/j.jsps.2018.04.004","journal-title":"Saudi Pharm J"},{"key":"4747_CR17","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1016\/j.xphs.2021.02.022","volume":"110","author":"MA Elfaky","year":"2021","unstructured":"Elfaky MA, Sirwi A, Tolba HH et al (2021) Development, optimization, and antifungal assessment of ocular gel loaded with ketoconazole cubic liquid crystalline nanoparticles. J Pharm Sci 110:2210\u20132220. https:\/\/doi.org\/10.1016\/j.xphs.2021.02.022","journal-title":"J Pharm Sci"},{"key":"4747_CR18","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1248\/cpb.c18-00615","volume":"66","author":"HM El-Laithy","year":"2018","unstructured":"El-Laithy HM, Badawi A, Abdelmalak NS, El-Sayyad N (2018) Cubosomes as oral drug delivery systems: a promising approach for enhancing the release of clopidogrel bisulphate in the intestine. Chem Pharm Bull 66:1165\u20131173. https:\/\/doi.org\/10.1248\/cpb.c18-00615","journal-title":"Chem Pharm Bull"},{"key":"4747_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s12010-023-04817-y","author":"HA El-Refai","year":"2024","unstructured":"El-Refai HA, Saleh AM, Mohamed SIA et al (2024) Biosynthesis of zinc oxide nanoparticles using Bacillus paramycoides for in vitro biological activities and in vivo assessment against hepatorenal injury induced by CCl4 in rats. Appl Biochem Biotechnol. https:\/\/doi.org\/10.1007\/s12010-023-04817-y","journal-title":"Appl Biochem Biotechnol"},{"key":"4747_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1208\/s12249-024-02814-w","volume":"25","author":"MM Faisal","year":"2024","unstructured":"Faisal MM, Gomaa E, Ibrahim AE et al (2024) Verapamil-loaded cubosomes for enhancing intranasal drug delivery: development, characterization, ex vivo permeation, and brain biodistribution studies. AAPS PharmSciTech 25:1\u201315. https:\/\/doi.org\/10.1208\/s12249-024-02814-w","journal-title":"AAPS PharmSciTech"},{"key":"4747_CR21","doi-asserted-by":"publisher","first-page":"20809","DOI":"10.1039\/d4ra02774d","volume":"14","author":"MM Fazil","year":"2024","unstructured":"Fazil MM, Gul A, Jawed H (2024) Optimization of silver nanoparticles synthesis via Plackett-Burman experimental design: in vitro assessment of their efficacy against oxidative stress-induced disorders. RSC Adv 14:20809\u201320823. https:\/\/doi.org\/10.1039\/d4ra02774d","journal-title":"RSC Adv"},{"key":"4747_CR22","doi-asserted-by":"publisher","first-page":"7415","DOI":"10.2147\/IJN.S265061","volume":"15","author":"DK Flak","year":"2020","unstructured":"Flak DK, Adamski V, Nowaczyk G et al (2020) At101-loaded cubosomes as an alternative for improved glioblastoma therapy. Int J Nanomedicine 15:7415\u20137431. https:\/\/doi.org\/10.2147\/IJN.S265061","journal-title":"Int J Nanomedicine"},{"key":"4747_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-020-02857-1","author":"SA Gaballa","year":"2020","unstructured":"Gaballa SA, El Garhy OH, Moharram H, Abdelkader H (2020) Preparation and evaluation of cubosomes\/cubosomal gels for ocular delivery of beclomethasone dipropionate for management of uveitis. Pharm Res. https:\/\/doi.org\/10.1007\/s11095-020-02857-1","journal-title":"Pharm Res"},{"key":"4747_CR24","first-page":"1","volume":"107","author":"T Geng","year":"2025","unstructured":"Geng T, Ding L, Liu M et al (2025) Preservation of Extracellular Vesicles for Drug Delivery\u202f: a Comparative Evaluation of Storage Buffers 107:1\u20136","journal-title":"Preservation of Extracellular Vesicles for Drug Delivery : a Comparative Evaluation of Storage Buffers"},{"key":"4747_CR25","doi-asserted-by":"publisher","first-page":"452","DOI":"10.4274\/tjps.galenos.2020.08522","volume":"18","author":"D Ghose","year":"2021","unstructured":"Ghose D, Patra CN, Ravi Kumar BVV et al (2021) QbD-based formulation optimization and characterization of polymeric nanoparticles of cinacalcet hydrochloride with improved biopharmaceutical attributes. Turk J Pharm Sci 18:452\u2013464","journal-title":"Turk J Pharm Sci"},{"key":"4747_CR26","doi-asserted-by":"publisher","first-page":"5113","DOI":"10.2147\/IJN.S261855","volume":"15","author":"KM Hosny","year":"2020","unstructured":"Hosny KM (2020) Nanosized cubosomal thermogelling dispersion loaded with saquinavir mesylate to improve its bioavailability: preparation, optimization, in vitro and in vivo evaluation. Int J Nanomedicine 15:5113\u20135129. https:\/\/doi.org\/10.2147\/IJN.S261855","journal-title":"Int J Nanomedicine"},{"key":"4747_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2020.129738","volume":"1865","author":"E Jab\u0142onowska","year":"2021","unstructured":"Jab\u0142onowska E, Matyszewska D, Nazaruk E et al (2021) Lipid membranes exposed to dispersions of phytantriol and monoolein cubosomes: langmuir monolayer and HeLa cell membrane studies. Biochimica et Biophysica Acta (BBA) 1865:129738. https:\/\/doi.org\/10.1016\/j.bbagen.2020.129738","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"4747_CR28","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1007\/s13346-021-01072-8","volume":"12","author":"S Kaul","year":"2022","unstructured":"Kaul S, Nagaich U, Verma N (2022) Preclinical assessment of nanostructured liquid crystalline particles for the management of bacterial keratitis: in vivo and pharmacokinetics study. Drug Deliv Transl Res 12:1719\u20131737. https:\/\/doi.org\/10.1007\/s13346-021-01072-8","journal-title":"Drug Deliv Transl Res"},{"key":"4747_CR29","doi-asserted-by":"publisher","first-page":"148","DOI":"10.18240\/ijo.2021.01.21","volume":"14","author":"NP Kesav","year":"2021","unstructured":"Kesav NP, Capitena Young CE, Ertel MK et al (2021) Sustained-release drug delivery systems for the treatment of glaucoma. Int J Ophthalmol 14:148\u2013159","journal-title":"Int J Ophthalmol"},{"key":"4747_CR30","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.ophtha.2024.01.007","volume":"131","author":"AJ King","year":"2024","unstructured":"King AJ, Hudson J, Azuara-Blanco A et al (2024) Evaluating primary treatment for people with advanced glaucoma: five-year results of the treatment of advanced glaucoma study. Ophthalmology 131:759\u2013770. https:\/\/doi.org\/10.1016\/j.ophtha.2024.01.007","journal-title":"Ophthalmology"},{"key":"4747_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2020.100901","volume":"82","author":"UB Kompella","year":"2021","unstructured":"Kompella UB, Hartman RR, Patil MA (2021) Extraocular, periocular, and intraocular routes for sustained drug delivery for glaucoma. Prog Retin Eye Res 82:100901. https:\/\/doi.org\/10.1016\/j.preteyeres.2020.100901","journal-title":"Prog Retin Eye Res"},{"key":"4747_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/advs.202408608","volume":"2408608","author":"W Lin","year":"2025","unstructured":"Lin W, Shen C, Li M et al (2025) Programmable Macrophage Vesicle Based Bionic Self-Adjuvanting Vaccine for Immunization against Monkeypox Virus 2408608:1\u201317. https:\/\/doi.org\/10.1002\/advs.202408608","journal-title":"Programmable Macrophage Vesicle Based Bionic Self-Adjuvanting Vaccine for Immunization against Monkeypox Virus"},{"key":"4747_CR33","doi-asserted-by":"publisher","unstructured":"Mahboobian MM, Mohammadi G, Mohammadi M (2021) Thermosensitive brinzolamide in situ gel nanoemulsions, in vitro and ex vivo evaluation. Biointerface Res Appl Chem 11:7754\u20137764.\u00a0https:\/\/doi.org\/10.33263\/BRIAC111.77547764","DOI":"10.33263\/BRIAC111.77547764"},{"key":"4747_CR34","unstructured":"Mayo Clinic Guide to Better Vision (2020) Glaucoma - symptoms and causes - Mayo Clinic. In: MAYO Clin"},{"key":"4747_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/NANO10050963","author":"O Mertins","year":"2020","unstructured":"Mertins O, Mathews PD, Angelova A (2020) Advances in the design of pH-sensitive cubosome liquid crystalline nanocarriers for drug delivery applications. Nanomaterials. https:\/\/doi.org\/10.3390\/NANO10050963","journal-title":"Nanomaterials"},{"key":"4747_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-024-58102-x","volume":"14","author":"B Mickky","year":"2024","unstructured":"Mickky B, Elsaka H, Abbas M et al (2024) Plackett-Burman screening of physico-chemical variables affecting Citrus peel-mediated synthesis of silver nanoparticles and their antimicrobial activity. Sci Rep 14:1\u201317. https:\/\/doi.org\/10.1038\/s41598-024-58102-x","journal-title":"Sci Rep"},{"key":"4747_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ph14080786","author":"M Nasr","year":"2021","unstructured":"Nasr M, Almawash S, Al Saqr A et al (2021) Bioavailability and antidiabetic activity of gliclazide-loaded cubosomal nanoparticles. Pharmaceuticals. https:\/\/doi.org\/10.3390\/ph14080786","journal-title":"Pharmaceuticals"},{"key":"4747_CR38","doi-asserted-by":"publisher","DOI":"10.1111\/ajco.13426","volume":"17","author":"A Oyman","year":"2021","unstructured":"Oyman A, Ba\u015fak M, \u00d6z\u00e7elik M et al (2021) Efficacy of abiraterone acetate in castration-resistant metastatic prostate cancer: a real-world data analysis. Asia Pac J Clin Oncol 17:e201. https:\/\/doi.org\/10.1111\/ajco.13426","journal-title":"Asia Pac J Clin Oncol"},{"key":"4747_CR39","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.fjps.2017.11.001","volume":"4","author":"KC Panigrahi","year":"2018","unstructured":"Panigrahi KC, Patra CN et al (2018) Gelucire: a versatile polymer for modified release drug delivery system. Future J Pharm Sci 4:102\u2013108. https:\/\/doi.org\/10.1016\/j.fjps.2017.11.001","journal-title":"Future J Pharm Sci"},{"key":"4747_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1208\/s12249-019-1411-2","volume":"20","author":"KC Panigrahi","year":"2019","unstructured":"Panigrahi KC, Patra CN, Rao MEB (2019) Quality by design enabled development of oral self-nanoemulsifying drug delivery system of a novel calcimimetic cinacalcet HCl using a porous carrier: in vitro and in vivo characterisation. AAPS PharmSciTech 20:1\u201317. https:\/\/doi.org\/10.1208\/s12249-019-1411-2","journal-title":"AAPS PharmSciTech"},{"key":"4747_CR41","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1080\/08982104.2018.1552703","volume":"29","author":"RP Patil","year":"2019","unstructured":"Patil RP, Pawara DD, Gudewar CS, Tekade AR (2019) Nanostructured cubosomes in an in situ nasal gel system: an alternative approach for the controlled delivery of donepezil HCl to brain. J Liposome Res 29:264\u2013273. https:\/\/doi.org\/10.1080\/08982104.2018.1552703","journal-title":"J Liposome Res"},{"key":"4747_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.fhfh.2023.100144","volume":"4","author":"H Rana","year":"2023","unstructured":"Rana H, Patel D, Thakkar V, Gandhi T (2023) Atovaquone smart lipid system: design, statistical optimization, and in-vitro evaluation. Food Hydrocoll Heal 4:100144. https:\/\/doi.org\/10.1016\/j.fhfh.2023.100144","journal-title":"Food Hydrocoll Heal"},{"key":"4747_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.stlm.2024.100144","volume":"13","author":"H Rana","year":"2024","unstructured":"Rana H, Chavada D, Thakkar V (2024a) Amalgamation of nano and 3-D printing technology: design, optimization, and assessment. Ann 3D Print Med 13:100144. https:\/\/doi.org\/10.1016\/j.stlm.2024.100144","journal-title":"Ann 3D Print Med"},{"key":"4747_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e29543","volume":"10","author":"H Rana","year":"2024","unstructured":"Rana H, Panchal M, Thakkar V et al (2024b) Investigating in-vitro functionality and in-vivo taste assessment of eco-friendly Tadalafil pastilles. Heliyon 10:e29543. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e29543","journal-title":"Heliyon"},{"key":"4747_CR45","doi-asserted-by":"publisher","first-page":"686","DOI":"10.4103\/IJO.IJO_379_23","volume":"71","author":"P Rewri","year":"2023","unstructured":"Rewri P (2023) Challenges of glaucoma management: towards better management of glaucoma in India. Indian J Ophthalmol 71:686\u2013688","journal-title":"Indian J Ophthalmol"},{"key":"4747_CR46","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/10717544.2021.1872740","volume":"28","author":"S Sayed","year":"2021","unstructured":"Sayed S, Abdel-Moteleb M, Amin MM, Khowessah OM (2021) Cubogel as potential platform for glaucoma management. Drug Deliv 28:293\u2013305. https:\/\/doi.org\/10.1080\/10717544.2021.1872740","journal-title":"Drug Deliv"},{"key":"4747_CR47","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.4103\/ijo.IJO","volume":"71","author":"P Seth","year":"2023","unstructured":"Seth P (2023) Prevalence of glaucoma types, clinical profile and disease severity at presentation: tertiary institute based cross-sectional study from South India. Indian J Ophthalmol 71:3305\u20133312. https:\/\/doi.org\/10.4103\/ijo.IJO","journal-title":"Indian J Ophthalmol"},{"key":"4747_CR48","doi-asserted-by":"publisher","first-page":"524","DOI":"10.2174\/1574885514666190916151506","volume":"15","author":"P Shah","year":"2019","unstructured":"Shah P, Thakkar V, Anjana V et al (2019) Exploring of Taguchi design in the optimization of brinzolamide and timolol maleate ophthalmic in-situ gel used in treatment of glaucoma. Curr Drug Ther 15:524\u2013542. https:\/\/doi.org\/10.2174\/1574885514666190916151506","journal-title":"Curr Drug Ther"},{"key":"4747_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.hsr.2023.100083","author":"Y Sharma","year":"2023","unstructured":"Sharma Y, Chahar K, Mishra L et al (2023) Recent overviews on the drug delivery aspects and applications of brinzolamide for the management of glaucoma. Health Sci Rev. https:\/\/doi.org\/10.1016\/j.hsr.2023.100083","journal-title":"Health Sci Rev"},{"key":"4747_CR50","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.ijpharm.2019.05.072","volume":"566","author":"B Shkodra","year":"2019","unstructured":"Shkodra B, Grune C, Traeger A et al (2019) Effect of surfactant on the size and stability of PLGA nanoparticles encapsulating a protein kinase C inhibitor. Int J Pharm 566:756\u2013764. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.05.072","journal-title":"Int J Pharm"},{"key":"4747_CR51","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-024-01739-y","volume":"15","author":"S Signorini","year":"2025","unstructured":"Signorini S, Pescina S, Ricci C et al (2025) Innovative formulations for the ocular delivery of coenzyme Q10. Drug Deliv Transl Res 15:39645537. https:\/\/doi.org\/10.1007\/s13346-024-01739-y","journal-title":"Drug Deliv Transl Res"},{"key":"4747_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118788","volume":"572","author":"E Simoni","year":"2019","unstructured":"Simoni E, Valente F, Boge L et al (2019) Biocompatibility of glycerol monooleate nanoparticles as tested on inner ear cells. Int J Pharm 572:118788. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118788","journal-title":"Int J Pharm"},{"key":"4747_CR53","doi-asserted-by":"publisher","DOI":"10.1177\/2280800020942712","author":"J Song","year":"2020","unstructured":"Song J, Zhang Z (2020) Brinzolamide loaded core-shell nanoparticles for enhanced coronial penetration in the treatment of glaucoma. J Appl Biomater Funct Mater. https:\/\/doi.org\/10.1177\/2280800020942712","journal-title":"J Appl Biomater Funct Mater"},{"key":"4747_CR54","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1016\/j.drudis.2019.02.001","volume":"24","author":"A Subrizi","year":"2019","unstructured":"Subrizi A, del Amo EM, Korzhikov-Vlakh V et al (2019) Design principles of ocular drug delivery systems: importance of drug payload, release rate, and material properties. Drug Discov Today 24:1446\u20131457","journal-title":"Drug Discov Today"},{"key":"4747_CR55","doi-asserted-by":"publisher","first-page":"175","DOI":"10.18231\/j.ijpp.2024.030","volume":"11","author":"SK Swain","year":"2024","unstructured":"Swain SK (2024) Gelucire\u202f: a wonderful excipient for improving the physicochemical characteristics of drugs and controlled release matrices. Indian J Pharm Pharmacol 11:175\u2013177","journal-title":"Indian J Pharm Pharmacol"},{"key":"4747_CR56","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1021\/acs.langmuir.0c03039","volume":"37","author":"T Terada","year":"2021","unstructured":"Terada T, Kulkarni JA, Huynh A et al (2021) Characterization of lipid nanoparticles containing ionizable cationic lipids using design-of-experiments approach. Langmuir 37:1120\u20131128. https:\/\/doi.org\/10.1021\/acs.langmuir.0c03039","journal-title":"Langmuir"},{"key":"4747_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14061150","author":"Y Wang","year":"2022","unstructured":"Wang Y, Wang C (2022) Novel eye drop delivery systems: advance on formulation design strategies targeting anterior and posterior segments of the eye. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics14061150","journal-title":"Pharmaceutics"},{"key":"4747_CR58","unstructured":"WHO (2023) Blindness and Vision Impairment"},{"key":"4747_CR59","first-page":"1","volume":"14","author":"Y Wu","year":"2019","unstructured":"Wu Y, Liu Y, Li X et al (2019) Research progress of in-situ gelling ophthalmic drug delivery system. Asian J Pharm Sci 14:1\u201315","journal-title":"Asian J Pharm Sci"},{"key":"4747_CR60","doi-asserted-by":"crossref","unstructured":"Wu Z, Sun W, Wang C (2024) Clinical characteristics, treatment, and outcomes of pembrolizumab - induced uveitis. 1\u201310","DOI":"10.1007\/s10637-024-01464-w"},{"key":"4747_CR61","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.apsb.2021.02.013","volume":"11","author":"A Yaghmur","year":"2021","unstructured":"Yaghmur A, Mu H (2021) Recent advances in drug delivery applications of cubosomes, hexosomes, and solid lipid nanoparticles. Acta Pharm Sin B 11:871\u2013885","journal-title":"Acta Pharm Sin B"},{"key":"4747_CR62","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1080\/03639045.2019.1590392","volume":"45","author":"M Yasser","year":"2019","unstructured":"Yasser M, Teaima M, El-Nabarawi M, El-Monem RA (2019) Cubosomal based oral tablet for controlled drug delivery of telmisartan: formulation, in-vitro evaluation and in-vivo comparative pharmacokinetic study in rabbits. Drug Dev Ind Pharm 45:981\u2013994. https:\/\/doi.org\/10.1080\/03639045.2019.1590392","journal-title":"Drug Dev Ind Pharm"},{"key":"4747_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-019-2182-0","volume":"11","author":"L Zhang","year":"2020","unstructured":"Zhang L, Li J, Tian D et al (2020) Theranostic combinatorial drug-loaded coated cubosomes for enhanced targeting and efficacy against cancer cells. Cell Death Dis 11:1\u201312. https:\/\/doi.org\/10.1038\/s41419-019-2182-0","journal-title":"Cell Death Dis"},{"key":"4747_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnano.2024.1359219","volume":"6","author":"C Zhu","year":"2024","unstructured":"Zhu C, Duan W, Jing H et al (2024) Improving the stability and transdermal permeability of phycocyanin loaded cubosomes. Front Nanotechnol 6:1\u201310. https:\/\/doi.org\/10.3389\/fnano.2024.1359219","journal-title":"Front Nanotechnol"},{"key":"4747_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.106026","volume":"100","author":"E Zingale","year":"2024","unstructured":"Zingale E, Bonaccorso A, Spadaro A et al (2024) Lipid-based nanocarriers mediated Axitinib retinal delivery after topical instillation: formulations setting up and in vivo evidence. J Drug Deliv Sci Technol 100:106026. https:\/\/doi.org\/10.1016\/j.jddst.2024.106026","journal-title":"J Drug Deliv Sci Technol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04747-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04747-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04747-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T08:00:39Z","timestamp":1772006439000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04747-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4747"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04747-y","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"24 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}